Clinical Trial Update: Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports the long-term efficacy and safety of intravitreal aflibercept injections for diabetic retinopathy in subjects who completed th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• EYLEA (Aflibercept)

Snippet

Sponsor: Greater Houston Retina Research | Conditions: Diabetic Retinopathy | Phase 4 | Status: COMPLETED